Catheter Precision, Inc.
VTAK
$0.29
$0.00521.83%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.41% | -27.82% | -3.13% | -3.53% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.41% | -27.82% | -3.13% | -3.53% | -- |
| Cost of Revenue | 57.14% | 66.67% | 128.57% | -50.00% | -- |
| Gross Profit | 14.05% | -32.28% | -13.48% | 2.67% | -- |
| SG&A Expenses | 13.52% | 4.99% | 91.73% | -74.04% | -65.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.43% | 3.21% | 80.59% | -74.26% | -66.41% |
| Operating Income | -17.48% | -4.73% | -86.10% | 74.84% | 67.99% |
| Income Before Tax | -271.75% | -113.80% | -167.77% | 95.97% | 91.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -741.26% | -113.80% | -167.77% | 95.97% | 91.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -741.26% | -113.80% | -167.77% | 95.97% | 91.80% |
| EBIT | -17.48% | -4.73% | -86.10% | 74.84% | 67.99% |
| EBITDA | -21.15% | -5.38% | -348.98% | 76.61% | 74.28% |
| EPS Basic | -19.54% | 29.05% | -89.66% | 98.54% | 97.52% |
| Normalized Basic EPS | 72.44% | 29.05% | -191.35% | 90.48% | 97.49% |
| EPS Diluted | -19.54% | 29.05% | -89.66% | 98.54% | 97.52% |
| Normalized Diluted EPS | 72.44% | 29.05% | -191.35% | 90.48% | 97.49% |
| Average Basic Shares Outstanding | 1,248.63% | 201.34% | 41.18% | 172.52% | 230.47% |
| Average Diluted Shares Outstanding | 1,248.63% | 201.34% | 41.18% | 172.52% | 230.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |